GT
ACHC icon

Glenmede Trust’s Acadia Healthcare ACHC Stock Holding History

Glenmede Trust’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Buy
14,566
+4,344
+42% +$112K ﹤0.01% 1039
2026
Q1 		$239K Buy
+10,222
New +$185K ﹤0.01% 1238
2025
Q1 		– Sell
-6,180
Closed -$245K – 1373
2024
Q4 		$245K Buy
6,180
+853
+16% +$38.5K ﹤0.01% 1173
2024
Q3 		$338K Buy
5,327
+1,528
+40% +$110K ﹤0.01% 1056
2024
Q2 		$257K Buy
3,799
+704
+23% +$49.2K ﹤0.01% 1106
2024
Q1 		$245K Buy
+3,095
New +$253K ﹤0.01% 1115
2020
Q4 		– Sell
-167
Closed -$4K – 1200
2020
Q3 		$4K Hold
167
– – ﹤0.01% 2117
2020
Q2 		$4K Buy
+167
New +$4.17K ﹤0.01% 2107
2019
Q2 		– Sell
-217
Closed -$6K – 3055
2019
Q1 		$6K Buy
217
+46
+27% +$1.3K ﹤0.01% 2540
2018
Q4 		$4K Sell
171
-1,000,583
-100% -$34.6M ﹤0.01% 2584
2018
Q3 		$35.2M Sell
1,000,754
-27,722
-3% -$1.1M 0.14% 235
2018
Q2 		$42.1M Buy
1,028,476
+40,147
+4% +$1.62M 0.19% 181
2018
Q1 		$32.2M Hold
988,329
– – 0.13% 231
2017
Q4 		$32.2M Sell
988,329
-197,030
-17% -$6.83M 0.13% 231
2017
Q3 		$56.6M Sell
1,185,359
-21,051
-2% -$1.03M 0.25% 110
2017
Q2 		$52.6M Hold
1,206,410
– – 0.25% 106
2017
Q1 		$52.6M Buy
1,206,410
+177,215
+17% +$7.19M 0.25% 106
2016
Q4 		$34.1M Sell
1,029,195
-21,565
-2% -$837K 0.19% 189
2016
Q3 		$52.1M Buy
1,050,760
+194,863
+23% +$10.1M 0.29% 88
2016
Q2 		$47.4M Buy
855,897
+150,459
+21% +$8.8M 0.29% 91
2016
Q1 		$38.9M Buy
705,438
+102,571
+17% +$5.85M 0.25% 106
2015
Q4 		$37.7M Buy
602,867
+98,375
+19% +$6.41M 0.26% 100
2015
Q3 		$33.4M Buy
504,492
+10,483
+2% +$806K 0.25% 113
2015
Q2 		$38.7M Sell
494,009
-81,215
-14% -$5.85M 0.28% 100
2015
Q1 		$41.2M Sell
575,224
-27,587
-5% -$1.77M 0.3% 84
2014
Q4 		$36.9M Buy
602,811
+176,510
+41% +$10.3M 0.29% 83
2014
Q3 		$20.7M Buy
+426,301
New +$20.8M 0.18% 170

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Glenmede Trust's ACHC Position: Q2 2026 in Review

Glenmede Trust increased its Acadia Healthcare (ACHC) stake by 42% in Q2 2026, buying an estimated $112K and bringing the position to 14,566 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Glenmede Trust first reported a position in ACHC in Q3 2014 and has held it in 27 quarters since. The position peaked at $56.6M in Q3 2017. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Glenmede Trust held 14,566 shares of Acadia Healthcare worth $430K as of Q2 2026.
  • Glenmede Trust bought 4,344 Acadia Healthcare shares in Q2 2026, an estimated $112K.
  • Acadia Healthcare made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1039 holding.
  • Glenmede Trust first reported a position in Acadia Healthcare in Q3 2014 and has held it in 27 quarters since.
  • Glenmede Trust's Acadia Healthcare position peaked at $56.6M in Q3 2017.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.